Skip to main content

Diabetes & Weight Loss News

The New England Journal of Medicine just published the results of a poll (1,290 votes from 75 countries) that asked readers to vote on the government regulation (e.g.,...
On July 17, the FDA approved Vivus’ weight-loss medication Qsymia (formerly called Qnexa), just several weeks after the approval of Arena’s Belviq (see new now next in...
The Journal of the American Medical Association (JAMA) published a controversial meta-analysis suggesting that people who are overweight (a body mass index [BMI] of 25-...
Dr. Arya Sharma highlights the most important weight loss tip everyone should know and why weight maintenance is a major achievement.
The giant Consumer Electronics Show, held each January in Las Vegas, had a variety of devices relevant to diabetes and obesity this year. Media buzz surrounded the...
On December 11, Orexigen announced the resubmission of its weight management drug Contrave (naltrexone/bupropion) to the FDA. The company has previously stated that it...
What do Michelle Obama, soda, and cities have in common? Our top five patient takeaways from PHA this year.
A controversial and groundbreaking ballot vote next month – how the Bay Area hopes to tackle diabetes and obesity.
Twitter summary: @omadahealth announces $950K in funding to bring #diabetes prevention program to low-income communities On September 17, Omada Health announced that it...
Twitter summary: AACE/ACE publish position statement on obesity w/ 4 step plan: screen, examine, evaluate, treat/prevent! Kudos 4 focus on proactive diagnosis The...
Twitter summary: Contrave launched in the US w/ weight support program + savings/loyalty programs offer new option for patients Two healthcare companies, Orexigen and...
What can obesity learn from seatbelts, airbags, and tobacco? Our interview with Robert Wood Johnson Foundation’s Dr. Marks.
How are the bacteria in our gut related to type 2 diabetes and obesity? The fascinating research.
The provocative documentary Fed Up , which offers an unflinching look at the real causes and challenges of America’s obesity epidemic, is currently playing in select...
Twitter summary: Exciting positive vote for #liraglutide #emdac on possible new therapy for #obesity! Plus, our favorite open public hearing yet. Yesterday on September...
Twitter summary: FDA approves Contrave weight management drug, with potential future use in #T2D On September 10, the FDA announced the approval of Orexigen’s weight...
Twitter summary: CDC releases state-by-state obesity data, several states see increases in adult obesity rates – childhood obesity rates level off The Center for Disease...
Twitter summary: After huge anticipation for this innovative drug combination, Novo Nordisk’s Xultophy received approval in Europe for #T2D, 1 st ever basal insulin/GLP-...
Current trial results show that obese patients using Contrave are about 41% less likely to experience any major heart event (e.g. heart attack, strokes, or heart-related...
Will it be the first US city to have warning labels for sugary drinks?

Pages